肝脏组织脂质在与代谢功能障碍相关的肥胖性肝脏疾病与糖尿病和肥胖症
Achuthan Sourianarayanane1, Christopher R Brydges2, Arthur J McCullough3
1Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及各种脂质变化. 肥胖和糖尿病显著改变了这些脂质特征,建议针对MASLD患者进行有针对性的干预.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢障碍 代谢障碍 代谢障碍
- 利皮多米克 (Lipidomics) 是一种消化剂.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 与异常的脂质代谢和肝脏脂肪积累有关.
- 在MASLD中的脂质积累在所有脂质类型中并不均.
- 这项研究调查了MASLD患者中脂质谱的变化.
研究的目的:
- 评估MASLD患者肝脏组织和血中的差异性脂质积累.
- 为了比较患有肥胖和/或糖尿病的和没有肥胖和/或糖尿病的MASLD患者之间的脂质概况.
主要方法:
- 来自72名MASLD参与者的肝脏和血样本的全面脂质组分析.
- 在MASLD患者和对照人群之间比较脂质资料.
- 基于肥胖和糖尿病状况的MASLD患者的分层.
主要成果:
- 没有肥胖或糖尿病的MASLD患者表现出明显的肝脂样.
- 肥胖和糖尿病进一步改变了肝脂质概况,观察到显著的相关性 (p < 0.05).
- 某些脂质 (脂肪酸,甘油三,胺) 的逐步增加和其他脂质 (脂) 的逐步减少,并增加了危险因素 (肥胖/糖尿病). 血脂的变化并不总是反映肝脏组织的发现.
结论:
- 根据肥胖和糖尿病的存在,MASLD中的脂质组成变化有所不同.
- 肥胖和糖尿病加剧了MASLD中的脂质乱,表明不同的代谢途径.
- 研究结果表明,根据MASLD患者的特定风险因素,有针对性治疗干预的潜力.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
相关概念视频
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Obesity
